Home > Oncology > ESMO 2020 > ESMO 2020 Highlights Podcast

ESMO 2020 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
ESMO 2020

 

  1. Nivolumab-cabozantinib doublet is effective as first-line treatment in advanced RCC
    Choueiri TK, et al. ESMO 2020 Virtual Meeting, abstract 696O.
  2. Trials with chemoimmunotherapy in metastatic TNBC show contradicting results
    Emens LA, et al. ESMO 2020 Virtual Meeting, abstract LBA16; Miles DW, et al. ESMO 2020 Virtual Meeting, abstract LBA15.
  3. Adjuvant osimertinib in NSCLC reduces risk of CNS recurrence
    Tsuboi M, et al. ESMO 2020 Virtual Meeting, abstract LBA1.
  4. CDK4/6 inhibitor palbociclib effective in ER+ advanced endometrial cancer
    Mirza MR, et al. ESMO 2020 Virtual Meeting, abstract LBA28.
  5. Nivolumab plus chemotherapy: new standard for first-line treatment of gastric cancer?
    Möhler M, et al. ESMO 2020 Virtual Meeting, abstract LBA6; Boku N, et al. ESMO 2020 Virtual Meeting, abstract LBA7.
  6. Lorlatinib outperforms crizotinib in ALK-positive advanced NSCLC
    Solomon B, et al. ESMO 2020 Virtual Meeting, abstract LBA2.


Posted on